This review discusses recent progress in the development of anti-HIV agents targeting the viral entry process. The three main classes (attachment inhibitors, co-receptor binding inhibitors, and fusion inhibitors) are further broken down by specific mechanism of action and structure. Many of these inhibitors are in advanced clinical trials, including the HIV maturation inhibitor bevirimat, from the authors' laboratories. In addition, the CCR5 inhibitor maraviroc has recently been FDA-approved. Possible roles for these agents in anti-HIV therapy, including treatment of virus resistant to current drugs, are also discussed. (c) 2008 Wiley Periodicals, Inc.
This review discusses recent progress in the development of anti-HIV agents targeting the viral entry process. The three main classes (attachment inhibitors, co-receptor binding inhibitors, and fusion inhibitors) are further broken down by specific mechanism of action and structure. Many of these inhibitors are in advanced clinical trials, including the pan class="Species">HIV maturation inhibitor bevirimat, from the authors' laboratories. In addition, the CCR5 inhibitor maraviroc has recently been FDA-approved. Possible roles for these agents in anti-HIV therapy, including treatment of virus resistant to current drugs, are also discussed. (c) 2008 Wiley Periodicals, Inc.
Authors: Christoph Seibert; Weiwen Ying; Svetlana Gavrilov; Fotini Tsamis; Shawn E Kuhmann; Anandan Palani; Jayaram R Tagat; John W Clader; Stuart W McCombie; Bahige M Baroudy; Steven O Smith; Tatjana Dragic; John P Moore; Thomas P Sakmar Journal: Virology Date: 2006-02-21 Impact factor: 3.616
Authors: E A Berger; R W Doms; E M Fenyö; B T Korber; D R Littman; J P Moore; Q J Sattentau; H Schuitemaker; J Sodroski; R A Weiss Journal: Nature Date: 1998-01-15 Impact factor: 49.962
Authors: J J Hale; R J Budhu; E B Holson; P E Finke; B Oates; S G Mills; M MacCoss; S L Gould; J A DeMartino; M S Springer; S Siciliano; L Malkowitz; W A Schleif; D Hazuda; M Miller; J Kessler; R Danzeisen; K Holmes; J Lineberger; A Carella; G Carver; E Emini Journal: Bioorg Med Chem Lett Date: 2001-10-22 Impact factor: 2.823
Authors: Laurie A Castonguay; Youmin Weng; William Adolfsen; Jerry Di Salvo; Ruth Kilburn; Charles G Caldwell; Bruce L Daugherty; Paul E Finke; Jeffrey J Hale; Christopher L Lynch; Sander G Mills; Malcolm MacCoss; Martin S Springer; Julie A DeMartino Journal: Biochemistry Date: 2003-02-18 Impact factor: 3.162
Authors: Sergey Pustylnikov; Rajnish S Dave; Zafar K Khan; Vanessa Porkolab; Adel A Rashad; Matthew Hutchinson; Frank Fieschi; Irwin Chaiken; Pooja Jain Journal: AIDS Res Hum Retroviruses Date: 2015-09-18 Impact factor: 2.205